AU7047381A - 1,4-dihydro-pyridines - Google Patents

1,4-dihydro-pyridines

Info

Publication number
AU7047381A
AU7047381A AU70473/81A AU7047381A AU7047381A AU 7047381 A AU7047381 A AU 7047381A AU 70473/81 A AU70473/81 A AU 70473/81A AU 7047381 A AU7047381 A AU 7047381A AU 7047381 A AU7047381 A AU 7047381A
Authority
AU
Australia
Prior art keywords
exception
carbon atoms
methyl
alkyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU70473/81A
Other versions
AU541935B2 (en
Inventor
Friedrich Bossert
Stanislav Kazda
Horst Meyer
Kurt Stoepel
Robertson Towart
Wulf Vater
Egbert Wehinger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU7047381A publication Critical patent/AU7047381A/en
Application granted granted Critical
Publication of AU541935B2 publication Critical patent/AU541935B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

1. Compound of the general formula I see diagramm : EP0039863,P18,F1 in which R represents a phenyl radical which optionally contains 1 or 2 identical or different substituents from the group comprising nitro, chlorine, cyano or trifluoromethyl, with the exception of a phenyl radical which is at the same time ortho- and metadichlorosubstituted, when R**2 denotes methyl and R**4 denotes alkyl with 2-3 carbon atoms, R**1 represents a saturated hydrocarbon radical with up to 6 carbon atons which is optionally interrupted by an oxygen atom, R**2 and R**4 are always different and each represents hydrogen, alkyl with 1 to 4 carbon atoms or cyclohexylmethyl, with the exception of the compound diethyl-2-methyl-6-propyl-4-(3-nitrophenyl)-1,4- dihydropyridine-3,5-carboxylate.
AU70473/81A 1980-05-13 1981-05-12 1,4-dihydro-pyridines Ceased AU541935B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19803018259 DE3018259A1 (en) 1980-05-13 1980-05-13 1,4-DIHYDROPYRIDINE WITH DIFFERENT SUBSTITUENTS IN 2- AND 6-POSITIONS, METHODS FOR THEIR PRODUCTION AND THEIR USE IN MEDICINAL PRODUCTS
DE30182593 1980-05-13

Publications (2)

Publication Number Publication Date
AU7047381A true AU7047381A (en) 1981-11-19
AU541935B2 AU541935B2 (en) 1985-01-31

Family

ID=6102290

Family Applications (1)

Application Number Title Priority Date Filing Date
AU70473/81A Ceased AU541935B2 (en) 1980-05-13 1981-05-12 1,4-dihydro-pyridines

Country Status (17)

Country Link
EP (1) EP0039863B1 (en)
JP (1) JPS577468A (en)
AT (1) ATE5718T1 (en)
AU (1) AU541935B2 (en)
CA (2) CA1175438A (en)
DE (2) DE3018259A1 (en)
DK (1) DK210281A (en)
ES (2) ES502132A0 (en)
FI (1) FI811437L (en)
GR (1) GR74910B (en)
HU (1) HU184434B (en)
IE (1) IE51267B1 (en)
IL (1) IL62841A (en)
NO (1) NO811424L (en)
PH (1) PH18747A (en)
PT (1) PT72964B (en)
ZA (1) ZA813141B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5158963A (en) * 1989-08-02 1992-10-27 Kaken Pharmaceutical Co., Ltd. 1-4-dihydropyridine derivative, process for preparing the same and pharmaceutical composition containing the same

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3207982A1 (en) * 1982-03-05 1983-09-08 Bayer Ag, 5090 Leverkusen NEW 1,4-DIHYDROPYRIDINE, METHOD FOR THE PRODUCTION AND USE THEREOF IN MEDICINAL PRODUCTS
DE3208628A1 (en) * 1982-03-10 1983-09-22 Bayer Ag, 5090 Leverkusen NEW COMPOUNDS, METHOD FOR THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS
US4414213A (en) * 1982-03-22 1983-11-08 Mead Johnson & Company Dihydropyridyl cyclic imidate esters and their pharmaceutical use
JPS58208271A (en) * 1982-04-30 1983-12-03 Kyowa Hakko Kogyo Co Ltd 1,4-dihydropyridine derivative
JPS6094963A (en) * 1983-10-31 1985-05-28 Teijin Ltd 1,4-dihydropyridine-3,5-dicarboxylic acid diester derivative and production thereof
NZ212895A (en) * 1984-08-22 1988-07-28 Glaxo Spa 1,4-dihydropyridine derivatives and pharmaceutical compositions
DE3447169A1 (en) * 1984-12-22 1986-07-03 Bayer Ag, 5090 Leverkusen OPTICALLY ACTIVE NITRODIHYDROPYRIDINE, METHOD FOR THE PRODUCTION AND THEIR USE IN MEDICINAL PRODUCTS
JPS625958A (en) * 1985-07-03 1987-01-12 Suntory Ltd 1,4-dihydropyridine derivative, production thereof and remedy for circulatory disease
US4761420A (en) * 1986-06-13 1988-08-02 Laboratoires Syntex S.A. Antihypertensive dihydropyridine derivatives
US5075324A (en) * 1986-12-24 1991-12-24 Boehringer Biochemia Robin S.P.A. Aralkyl-1,4-dihydropyridines, a method for their preparation and pharmaceutical composition containing them
WO1991009847A1 (en) * 1989-12-29 1991-07-11 Kaken Pharmaceutical Co., Ltd. Ethynylphenyl derivative, production thereof, and remedy for diseases of circulatory organs containing the same as active ingredient
DE59410255D1 (en) * 1993-12-10 2003-04-17 Bayer Ag Phenyl-substituted 1,4-dihydropyridines with cerebral activity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1792764C3 (en) * 1967-03-20 1981-04-23 Bayer Ag, 5090 Leverkusen Coronary drugs
GB1430961A (en) * 1972-01-22 1976-04-07 Yamanouchi Pharma Co Ltd 1-substituted-1,4-dihyddrypyridine derivatives
DE2508181A1 (en) * 1975-02-26 1976-09-09 Bayer Ag 1,4-DIHYDROPYRIDINCARBONIC ACID ARAL KYLESTER, METHOD FOR MANUFACTURING AND USING THEY AS A MEDICINAL PRODUCT
GB1591089A (en) * 1976-12-17 1981-06-10 Fujisawa Pharmaceutical Co 1,4-dihydropyridine derivatives and process for preparation thereof
SE7910521L (en) * 1979-12-20 1981-06-21 Haessle Ab NEW 2-METHYL-6-SUBSTITUTED-4- (2,3-DISUBSTITUTED PHENYL) -1,4-DIHYDROPYRIDINE-3,5-DIESTERS WITH HYPOTHESIVE PROPERTIES, AND PROCEDURES FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATION

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5158963A (en) * 1989-08-02 1992-10-27 Kaken Pharmaceutical Co., Ltd. 1-4-dihydropyridine derivative, process for preparing the same and pharmaceutical composition containing the same

Also Published As

Publication number Publication date
GR74910B (en) 1984-07-12
PT72964A (en) 1981-06-01
EP0039863A1 (en) 1981-11-18
ES8300093A1 (en) 1982-10-01
EP0039863B1 (en) 1983-12-28
CA1175438A (en) 1984-10-02
ATE5718T1 (en) 1984-01-15
IL62841A0 (en) 1981-07-31
IE51267B1 (en) 1986-11-26
FI811437L (en) 1981-11-14
CA1185182A (en) 1985-04-09
ZA813141B (en) 1982-04-28
ES8304082A1 (en) 1983-02-16
PT72964B (en) 1982-06-25
NO811424L (en) 1981-11-16
IE811061L (en) 1981-11-13
AU541935B2 (en) 1985-01-31
ES512592A0 (en) 1983-02-16
DE3018259A1 (en) 1981-11-19
DK210281A (en) 1981-11-14
HU184434B (en) 1984-08-28
DE3161760D1 (en) 1984-02-02
PH18747A (en) 1985-09-19
ES502132A0 (en) 1982-10-01
JPS577468A (en) 1982-01-14
IL62841A (en) 1984-11-30

Similar Documents

Publication Publication Date Title
AU541935B2 (en) 1,4-dihydro-pyridines
GB1500581A (en) Substituted amides and their use as fungicides
ES455909A1 (en) 1,4-Substituted piperazinyl derivatives useful as psychostimulants
ES8305729A1 (en) intermediates, useful in their preparation and a process for the preparation thereof.
ATE1904T1 (en) 2-SULFONYL-QUINOXALINES, PROCESSES FOR THEIR PRODUCTION AND USE AS MICROBICIDES.
ES476632A1 (en) Heterocyclic-substituted anilide derivatives, a process for their preparation, herbicidal compositions containing them and a method of controlling undesired plant growth using them.
GB1430926A (en) 2-amino-3,4-dihydropyridines their production and their medicinal use
GB1509864A (en) Pyridine-4-carboxylic acid hydrazides and pyridine-4-carboxylic acid hydrazones for combatting microorganisms and for regulating plant growth
DE3462031D1 (en) Alpha,alpha-dimethylphenylacetanilide derivatives, process for production thereof, and use thereof as insecticide
GB1512620A (en) Derivatives of dithiepino(1,4)(2,3-c)pyrrole
EP0201203A3 (en) Method of treatment of plants with aniline derivatives
ES8501408A1 (en) Triorganotin acetylsalicylates and biocidal compositions containing them.
DE3261271D1 (en) N-fluorinated benzyl amides and process for their preparation
ATE50569T1 (en) ALPHA-ALLYLATED ARYLALKYLTRIAZOLES, PROCESS FOR THEIR PRODUCTION AND THEIR USE AS FUNGICIDES.
TH2282EX (en) Phenylsulfonylguanidine with a new class of substitutes for the control of weeds and trail mixtures.
IE37963B1 (en) A disinfectant composition incorporating mono-oxycarboxylate salts of bis-biguanidines
JPS5543088A (en) Preparation of isoxazole derivative
TH2671A (en) Thiolen-2,4-dion-3-carboxamid
TH945EX (en) Fungicide
TH1794EX (en) Tetrahydro-pyran-3,5-dion-4-carboxamid replaced.
TH3875A (en) Herbicides N- (phosphonomethyl glycyl) sulfonilamine
RO81676B (en) Process for preparing n-aryl-n-acyl-3-amino-oxazolidin-2-ones with fungicidal activity
GB1298481A (en) Herbicide